Catalent to make active ingredient for AstraZeneca’s COVID-19 vaccine candidate

Catalent Inc said on Monday it will manufacture active ingredient for AstraZeneca Plc and the University of Oxford’s COVID-19 vaccine candidate.

It will be made at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland, the company said.

https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-Catalent-to-make-active-ingredient-for-AstraZeneca-s-COVID-19-vaccine-candidate-31166267/